All About Vaccines

All About Vaccines

The GBS|CIDP Foundation is committed to sharing the most accurate information from the world’s leading experts, many from our Global Medical Advisory Board. The articles below, dating back to 2019, have been published in prestigious peer-reviewed medical journals, and offer a wide range of research and information on various vaccines, including COVID-19, as they relate to GBS, CIDP, MMN or related conditions. We understand that there are many opinions creating confusion regarding vaccines, so please consider the source of your information before drawing conclusions. Each of these articles have been reviewed, vetted and recommended as resources by our Global  Medical Advisory Board. As always, all decisions should be made with your personal physician based on your own health.

Monkey Pox:

Our recommendation on Monkey Pox vaccine falls in line with our general position on other vaccines. We do not have any “real world” data on this, but vaccines are safe and effective. While nothing is completely risk-free, benefits of vaccination outweigh unproven and unlikely risk.

-Dr. Jeff Allen, Global Medical Advisory Board Member

Risk of Guillain–Barré Syndrome After Vaccination

Patients’ Attitude Towards Vaccination after Guillain-Barré Syndrome

Rate of Recurrent GBS after mRNA COVID-19 Vaccine

Guillain-Barré Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence

Guillain-Barré Syndrome After High-Dose Influenza Vaccine Administration in the United States

Adverse events following HPV vaccination: 11 years of surveillance in Australia

Monitoring the Safety of High-Dose, Trivalent Inactivated Influenza Vaccine

Do Vaccines Trigger Neurological Diseases?

COVID-19

✕